Molecular dynamics analysis of potent inhibitors of M2 proton channel against H1N1 swine influenza virus

Molecular Simulation

Volumn 37, Issue 3, 2011, Pages 250-256

  Lai, Chia Yu ^a,b   Chang, Tung Ti ^a,b   Sun, Mao Feng ^a,b   Chen, Hsin Yi ^c   Tsai, Fuu Jen ^a,c   Lin, Jaung Geng ^a   Chen, Calvin Yu Chian ^a,c,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d USA   (United States)

Author keywords

docking; H1N1; M2 proton channel; molecular dynamics; traditional Chinese medicine (TCM)

Indexed keywords

ANTI-VIRAL DRUGS; BIO-MOLECULAR; CLINICAL STUDY; CLINICAL USAGE; DE NOVO DESIGN; GENIPIN; H1N1; INFLUENZA PANDEMICS; INFLUENZA VIRUS; M2 PROTON CHANNEL; MOLECULAR DOCKING; MOLECULAR DYNAMICS SIMULATIONS; NEURAMINIDASE; POTENT INHIBITOR; PROTON CHANNELS; TRADITIONAL CHINESE MEDICINE;

DOCKING; DYNAMICS; MEDICINE; PROTONS; VIRUSES;

MOLECULAR DYNAMICS;

EID: 79952662112     PISSN: 08927022     EISSN: 10290435     Source Type: Journal    
DOI: 10.1080/08927022.2010.543972     Document Type: Article

References (46)

1. A. Helenius, Unpacking the incoming influenza virus, Cell 69 (1992), pp. 577-578.
2. L.H. Pinto and R.A. Lamb, The M2 proton channels of influenza A and B viruses, J. Biol. Chem. 281 (2006), pp. 8997-9000. (Pubitemid 43864610)
3. R.J. Sugrue and A.J. Hay, Structural characteristics of the M2 protein of influenza A viruses: Evidence that it forms a tetrameric channel, Virology 180 (1991), pp. 617-624.
4. L.H. Pinto, G.R. Dieckmann, C.S. Gandhi, C.G. Papworth, J. Braman, M.A. Shaughnessy, J.D. Lear, R.A. Lamb, and W.F. DeGrado, A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity, Proc. Natl Acad. Sci. USA 94 (1997), pp. 11301-11306.
5. N.A. Ilyushina, E.A. Govorkova, and R.G. Webster, Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia, Virology 341 (2005), pp. 102-106. (Pubitemid 41356578)
6. P.K. Cheng, T.W. Leung, E.C. Ho, P.C. Leung, A.Y. Ng, M.Y. Lai, and W.W. Lim, Oseltamivir- and amantadine-resistant influenza viruses A (H1N1), Emerg. Infect. Dis. 15 (2009), pp. 966-968.
7. Q.S. Du, R.B. Huang, S.Q. Wang, and K.C. Chou, Designing inhibitors of M2 proton channel against H1N1 swine influenza virus, Plos One 5 (2010), e9388.
8. Y.J. Tang, J.S. Yang, C.F. Lin, W.C. Shyu, M. Tsuzuki, C.C. Lu, Y.F. Chen, and K.C. Lai, Houttuynia cordata Thunb extract induces apoptosis through mitochondrial-dependent pathway in HT-29 human colon adenocarcinoma cells, Oncol. Rep. 22 (2009), pp. 1051-1056.
9. C.R. Su, Y.F. Chen, M.J. Liou, H.Y. Tsai, W.S. Chang, and T.S. Wu, Anti-inflammatory activities of furanoditerpenoids and other constituents from Fibraurea tinctoria, Bioorgan. Med. Chem. 16 (2008), pp. 9603-9609.
10. Y.H. Hsieh, F.H. Chu, Y.S. Wang, S.C. Chien, S.T. Chang, J.F. Shanw, C.Y. Chen, W.W. Hsiao, Y.H. Kuo, and S.Y. Wang, Antrocamphin A, an anti-inflammatory principal from the fruiting body of Taiwanofungus camphoratus, and its mechanisms, J. Agric. Food Chem. 58 (2010), pp. 3153-3158.
11. C.D. Yoo, S.C. Kim, and S.H. Lee, Molecular dynamics simulation study of probe diffusion in liquid n-alkanes, Mol. Simulat. 35 (2009), pp. 241-247.
12. D.X. Li, G.L. Chen, B.L. Liu, and Y.S. Liu, Molecular simulation of β-cyclodextrin inclusion complex with 2-phenylethyl alcohol, Mol. Simulat. 35 (2009), pp. 199-204.
13. F. Luan, H.T. Liu, Y. Gao, and X.Y. Zhang, QSPR model to predict the thermal stabilities of second-order nonlinear optical (NLO) chromophore molecules, Mol. Simulat. 35 (2009), pp. 248-257.
14. J.H. Jing, G.Z. Liang, H. Mei, S.Y. Xiao, Z.N. Xia, and Z.L. Li, Quantitative structure-mobility relationship studies of dipeptides in capillary zone electrophoresis using three-dimensional holographic vector of atomic interaction field, Mol. Simulat. 35 (2009), pp. 263-269.
15. A.M. Al-Mekhnaqi, M.S. Mayeed, and G.M. Newaz, Prediction of protein conformation in water and on surfaces by Monte Carlo simulations using united-atom method, Mol. Simulat. 35 (2009), pp. 292-300.
16. M.L. Mihajlovic and P.M. Mitrasinovic, Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs), Mol. Simulat. 35 (2009), pp. 311-324.
17. K. Roy and G. Ghosh, QSTR with extended topochemical atom (ETA) indices. 11. Comparative QSAR of acute NSAID cytotoxicity in rat hepatocytes using chemometric tools, Mol. Simulat. 35 (2009), pp. 648-659.
18. P. Nimmanpipug, V.S. Lee, P. Wolschann, and S. Hannongbua, Litchi chinensis-derived terpenoid as anti-HIV-1 protease agent: Structural design from molecular dynamics simulations, Mol. Simulat. 35 (2009), pp. 673-680.
19. P. Ghosh and M.C. Bagchi, Comparative QSAR studies of nitrofuranyl amide derivatives using theoretical structural properties, Mol. Simulat. 35 (2009), pp. 1185-1200.
20. Y.S. Zhao, Q.C. Zheng, H.X. Zhang, H.Y. Chu, and C.C. Sun, Homology modelling and molecular dynamics study of human fatty acid amide hydrolase, Mol. Simulat. 35 (2009), pp. 1201-1208.
21. C.Y. Chen, Insights into designing the dual-targeted HER2/HSP90 inhibitors, J. Mol. Graph Model. 29 (2010), pp. 21-31.
22. H.J. Huang, K.J. Lee, H.W. Yu, H.Y. Chen, F.J. Tsai, and C.Y.C. Chen, A novel strategy for designing the selective PPAR agonist by the "Sum of Activity" model, J. Biomol. Struct. Dyn. 28 (2010), pp. 187-200.
23. H.J. Huang, K.J. Lee, H.W. Yu, C.Y. Chen, C.H. Hsu, H.Y. Chen, F.J. Tsai, and C.Y.C. Chen, Structure-based and ligand-based drug design for HER2 receptor, J. Biomol. Struct. Dyn. 28 (2010), pp. 23-37.
24. H.J. Huang, C.Y. Chen, H.Y. Chen, F.J. Tsai, and C.Y.C. Chen, Computational screening and QSAR analysis for design of AMPactivated protein kinase agonist, J. Taiwan Inst. Chem. E 41 (2010), pp. 352-359.
25. C.Y.C. Chen, Virtual screening and drug design for PDE-5 receptor from traditional chinese medicine database, J. Biomol. Struct. Dyn. 27 (2010), pp. 627-640.
26. C.Y.C. Chen, Bioinformatics, chemoinformatics, and pharmainformatics analysis of HER2/HSP90 dual-targeted inhibitors, J. Taiwan Inst. Chem. E 41 (2010), pp. 143-149.
27. C.Y. Chen, H.J. Huang, F.J. Tsai, and C.Y.C. Chen, Drug design for influenza: A virus subtype H1N1, J. Taiwan Inst. Chem. E 41 (2010), pp. 8-15.
28. C.Y.C. Chen, Weighted equation and rules - A novel concept for evaluating protein-ligand interaction, J. Biomol. Struct. Dyn. 27 (2009), pp. 271-282.
29. C.Y.C. Chen, Computational screening and design of traditional Chinese medicine (TCM) to block phosphodiesterase-5, J. Mol. Graph Model. 28 (2009), pp. 261-269.
30. C.Y. Chen, Y.H. Chang, D.T. Bau, H.J. Huang, F.J. Tsai, C.H. Tsai, and C.Y.C. Chen, Ligand-based dual target drug design for H1N1: Swine flu - A preliminary first study, J. Biomol. Struct. Dyn. 27 (2009), pp. 171-178.
31. C.Y. Chen, Y.H. Chang, D.T. Bau, H.J. Huang, F.J. Tsai, C.H. Tsai, and C.Y.C. Chen, Discovery of potent inhibitors for phosphodiesterase 5 by virtual screening and pharmacophore analysis, Acta Pharmacol. Sin. 30 (2009), pp. 1186-1194.
32. C.Y.C. Chen, Pharmacoinformatics approach for mPGES-1 in antiinflammation by 3D-QSAR pharmacophore mapping, J. Taiwan Inst. Chem. E 40 (2009), pp. 155-161.
33. C.Y.C. Chen, De novo design of novel selective COX-2 inhibitors: From virtual screening to pharmacophore analysis, J. Taiwan Inst. Chem. E 40 (2009), pp. 55-69.
34. C.Y.C. Chen, Chemoinformatics and pharmacoinformatics approach for exploring the GABA-A agonist from Chinese herb suanzaoren, J. Taiwan Inst. Chem. E 40 (2009), pp. 36-47.
35. C.Y.C. Chen, Insights into the suanzaoren mechanism - From constructing the 3D structure of GABA-A receptor to its binding interaction analysis, J. Chin. Inst. Chem. Eng. 39 (2008), pp. 663-671.
36. C.Y.C. Chen, Discovery of novel inhibitors for c-Met by virtual screening and pharmacophore analysis, J. Chin. Inst. Chem. Eng. 39 (2008), pp. 617-624.
37. C.Y.C. Chen, Y.F. Chen, C.H. Wu, and H.Y. Tsai, What is the effective component in suanzaoren decoction for curing insomnia? Discovery by virtual screening and molecular dynamic simulation, J. Biomol. Struct. Dyn. 26 (2008), pp. 57-64.
38. C.Y.C. Chen, A novel perspective on designing the inhibitor of HER2 receptor, J. Chin. Inst. Chem. Eng. 39 (2008), pp. 291-299.
39. C.Y.C. Chen, G.W. Chen, and W.Y.C. Chen, Molecular simulation of HER2/neu degradation by inhibiting HSP90, J. Chin. Chem. Soc.- Taiwan 55 (2008), pp. 297-302.
40. Y.C. Chen and K.T. Chen, Novel selective inhibitors of hydroxyxanthone derivatives for human cyclooxygenase-2, Acta Pharmacol. Sin. 28 (2007), pp. 2027-2032.
41. Y.C. Chen, The molecular dynamic simulation of zolpidem interaction with gamma aminobutyric acid type A receptor, J. Chin. Chem. Soc.-Taiwan 54 (2007), pp. 653-658.
42. A.L. Stouffer, R. Acharya, D. Salom, A.S. Levine, L. Di Costanzo, C.S. Soto, V. Tereshko, V. Nanda, S. Stayrook, and W.F. DeGrado, Structural basis for the function and inhibition of an influenza virus proton channel, Nature 451 (2008), pp. 596-599. (Pubitemid 351186271)
43. V.M. Deyde, X.Y. Xu, R.A. Bright, M. Shaw, C.B. Smith, Y. Zhang, Y.L. Shu, L.V. Gubareva, N.J. Cox, and A.I. Klimov, Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide, J. Infect. Dis. 196 (2007), pp. 249-257. (Pubitemid 47047464)
44. H.J. Bohm, The computer program LUDI: A new method for the de novo design of enzyme inhibitors, J. Comput. Aided Mol. Des. 6 (1992), pp. 61-78.
45. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliver Rev. 46 (2001), pp. 3-26. (Pubitemid 33653411)
46. J. Hu, R. Fu, K. Nishimura, L. Zhang, H.X. Zhou, D.D. Busath, V. Vijayvergiya, and T.A. Cross, Histidines, heart of the hydrogen ion channel from influenza A virus: Toward an understanding of conductance and proton selectivity, Proc. Natl Acad. Sci. USA 103 (2006), pp. 6865-6870.